96

-
50

1.

25

?
(A) PID
(B) Pelvic congestion syndrome
(C) Ectopic pregnancy (D) Endometriosis
Ans(D) ()

2.

44 , G3P2SA1
30 6~8
, 3~4
Hb:11g/dl,

(A) ,
(B) ,
(C) ,
(D)
Ans(A) ()

3.

38 G2P2

?
(A) Excision of vulvar nodule
(B) Medical treatment with antibiotic & analgesic drugs
(C) Marsulpialization
(D) Estrogen replacement therapy
Ans(C) ()

1 / 9

4.

15 , (menarche)

?
(A) Asherman's syndrome
(C) inperforated hymen
Ans(C) ()

(B) premature ovarian failure

(D) pituitary tumor

5.

48 G3P3
10x9cm
HPV
?
(A) , ,
(B) , ,
(C) ,
(D) ? , .
Ans(B) ()

6.

(A) (B) perineal body (C)

AnsD

(D)

7.

58 G4P4 20 5

(A) (B)
(C)
(D)
AnsB

8.

(A) 100 c.c (B) 200 c.c

(C) 50 c.c
AnsC

9.

(D) 150 c.c

(A)
(B) (submucosal)
(C) 35 20%
(D) (red degeneration)
AnsB

10.
(A) Myomectomy
(C) Ovarian cancer

(B) Ovarian tumor during pregnancy

(D) Cervical cancer
2 / 9

AnsC
11. (LAVH)

(A) Subcutaneous emphysema

(C) Ureter injury
AnsB

(B) Bladder injury

(D) Vascular injury

12. (ovarian reserve)

Reduced ovarian reserve
unexplained infertility reduced ovarian reserve

40 reduced ovarian reserve

25
Reduced ovarian reserve size

(A) (B) (C) (D) (E)

AnsC
13.
2003 34% 28%
43 40~49%
1 2~6%
43 50%

(A) (B) (C) (D)

(E)
AnsA
14. 43 21
?
(A)10% (B)20% (C)30% (D)40% (E)50%
AnsE
15.
5%
E2 P4

3 / 9


( IUI)
?
(A) (B)
(C) (D) (E)
AnsE
16. 38 stage Ib1

(A) (B) (C) (D)

AnsD
17. 60 CSerous
adenocarcinoma?
(A) Carboplatin, Paclitaxel (B) Cisplatin, Cyclophosphamide
(C) Cisplatin, Gemcitabine (D) Epirubicin, Cyclophosphamide
AnsA
18. 35 16 CIN3:
(A) (B) 3
(C) (D)
AnsA
19. 58

(A) I (B) II (C) III (D) IV

AnsA

20. HPV
(A) condyloma acuminata type 6 11
(B) cervical cancer type 16 18
(C)HPV
(D) HPV 16 18 cervical cancer
AnsC
21.
(A) 3
(B)
4 / 9

(C)40
(D)
AnsA
22.
(A) LOA (B) LOT (C) ROA (D) OA
AnsA ()
23.
(A) (B) (C)
(D)
AnsD ()
24. (1) (2) (3) (4)
(5)
(A) 1, 2, 3, 4, 5
(B) 3, 2, 4, 1, 5
(C) 2, 3, 4, 1, 5
(D) 4, 2, 1, 3, 5
AnsB ()
25. (Shoulder dystocia)
(A)
(B)
(C)
(D)
AnsD ()
26. 50
(A) 16~18 (B) 20~22 (C) 24~28 (D) 30~32
AnsC
27. 30 G3P2 32
?
(A) (B) (C)
(D)
(E)
AnsD

5 / 9

28.
cc 1200 33% 40%
?
(A)Mild oligozoospermia
(B)Mild oligoteratozoospermia
(C)Moderate oligoasthenoteratozoospermia
(D)Mild oligoasthenozoospermia
(E)Severe oligoteratozoospermia
AnsD
29. 18
hCG level 700 mIU/Ml
?
(A)
(B),
(C),
(D)
(E)MRI scan
AnsD

30. 34

Mycostatin vaginal tablet

Wet mount Clue cell hyphae
Whiff test

?
(A) (B) (C)
(D) (E)
AnsB
31. hyperprolactinemia
hyperprolactinemia amenorrhea or oligomenorrhea

30%
?
(A) (B) (C)
(D) (E)
AnsE
32. 33 adenomyosis?
6 / 9

(A) (B) (C) (D) (E)

AnsD
33.
(A) 90~130
(B) 100~140
(C) 110~150
(D) 120~160
(E) 130~170
AnsD
34. 25 8 158
75
3~8mm
(A)
(B)
(C)
(D)
(E)
AnsC
35. ?
(A)
(B) A G7
(C) X G
(D) q
AnsB

36. Klinefelter syndrome ?

(A) XXY (B) (C)
AnsD

(D)

37. ?
(A) Turner syndrome
(C) Down syndrome
AnsC

(B) Klinefelter syndrome

(D) Trisomy 13

38. ?
(A)HIV
(B) (C) (D)
AnsB
39. HPV ?
(A) HPV
(B) HPV RNA
7 / 9

(C) 50% HPV HPV

(D) HPV
AnsB
40. , , ,
?
(A) (B)HSG (C)
(D)
AnsA

41.
(A)latent phase
active phase
(B) 4
(C) 6 3
(D)prolonged latent phase
20 14
AnsC
42. 12

(A)spina bifida (B)anencephaly

(C)hydrocephaly (D)hydronephrosis
AnsB
43. , 25 , BBT 15~16 ,
Lutel Phase Defect , ?
(A) clomid (B) progesterone (C) estrogen (D)
HCG
AnsC
44. Ultrasound is most useful in evaluating fetal anatomy
(A) between 2 and 4 weeks after LMP
(B) between 7 and 9 weeks after LMP
(C) between 12 and 14 weeks after LMP
(D) between 19 and 21 weeks after LMP
AnsD ()
45. A missed abortion is the death of the fetus
(A) that the patient does not realize has occurred
(B) in which the products of conception are retained after the embryo or fetus has
died
8 / 9

(C) in which the products of conception are partially expelled

(D) in which the products of conception cause bleeding and there is an open
cervical os
AnsB ()
46. Although all of the following can be the cause for postpartum hemorrhage,
which is the most frequent cause of immediate hemorrhage as seen in this
patient?
(A) uterine atony
(B) vaginal and / or cervical lacerations
(C) coagulopathies
(D)uterine rupture
AnsA ()
47. The most likely cause of abnormal genital bleeding in a 13-year-old girl is
(A) uterine cancer (B) ectopic pregnancy
(C) anovulation
(D) systemic bleeding diatheses
AnsC ()
48. A 30-year-old woman complains of 36 hours of urinary frequency, dysuria, and
pelvic pain. She has never had a UTI and has no medical problems.The most
likely pathogen is
(A) Escherichia coli
(B) Staphylococcus saprophyticus
(C) Klebsiella pneumonia
(D) Proteus mirabilis
AnsA ()
49. The most important principle in the treatment of ovarian cancer is
(A) removal of all resectable disease
(B) examination of tumor cells cultured in vitro
(C) choice of chemotherapy
(D) calculation of radiation dose
AnsA ()
50. Ritodrine is a beta-adrenergic receptor stimulator that is used to arrest preterm
labor. Which of the following is a major maternal risk associated with its use?
(A) hypertension
(B) decreased plasma glucose
(C) decreased serum potassium
(D) cardiac arrhythmias
AnsD ()

9 / 9